Bilimsel Makale Arama | NeuralCipher AI

Açık erişim

Imaging brain class I histone deacetylase changes in the Lewy body dementias and Parkinson's disease.

Goodheart AE, Yoo CH, Fassini A, Dagnew TM, Ye R, Striar R, Quan M, Rattray AK, Meyer TN, Peterec E, Lee H, Fiedler SA, Hooker JM, Wey HY, Wang C, Gomperts SN.

Clin Epigenetics · 2026-01-24

DOI: 10.1186/s13148-026-02054-8PMID: 41580847

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Comparative evaluation of standardized imaging-guided contact selection for subthalamic deep brain stimulation in Parkinson's disease: study protocol for a randomized double-blind crossover trial.

Brandt GA, Piotrowsky L, Petry-Schmelzer JN, van der Linden C, Schedlich-Teufer C, Visser-Vandewalle V, Dembek TA, Barbe MT.

Trials · 2025-12-30

DOI: 10.1186/s13063-025-09396-3PMID: 41469687

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Automated radiosynthesis and clinical experience of [18F]SMBT-1 PET imaging for in vivo evaluation of reactive astrocyte in Parkinson's disease: a pilot study.

Kiatkittikul P, Lerdsirisuk P, Bhuthathorn L, Choolam A, Jantarato A, Kongsakorn P, Chintawan W, Sringam T, Fonghoi N, Vanprom S, Harada R, Okamura N, Furumoto S, Promteangtrong C.

Front Nucl Med · 2025-12-08

DOI: 10.3389/fnume.2025.1718255PMID: 41437980

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

CX3CR1: a potential microglia-specific PET imaging target in Alzheimer's and Parkinson's diseases.

Yang H, Wang Y, Xu Y, Wang C.

Front Pharmacol · 2025-12-04

DOI: 10.3389/fphar.2025.1678159PMID: 41424797

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Correlation analysis of 11C-CFT PET/CT parameters with clinical characteristics of patients with early to mid-stage Parkinson's disease.

Zhu T, Zuo R, Xia Z, Li W, Guan L, Chen J, Xu L, Pang H.

BMC Med Imaging · 2025-11-28

DOI: 10.1186/s12880-025-02081-6PMID: 41315983

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Multimodal PET/MR Imaging in Early-onset Alzheimer's Disease With Parkinsonism due to a Novel Presenilin-1 (M233I) Mutation.

Fang H, Tang A, Tang C, Lan X, Sun X.

Clin Nucl Med · 2025-11-21

DOI: 10.1097/rlu.0000000000006238PMID: 41363940

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Characteristics of brain glucose metabolism in Parkinson's disease patients with freezing of gait: a study based on 18F-FDG PET imaging and deep learning.

Zhu Z, Geng Y, Wang X, Shi J, Wang H, Liu L, Li S, Gan C, Yuan Y, Zhu Q, Zhang K.

BMC Neurol · 2025-10-31

DOI: 10.1186/s12883-025-04468-yPMID: 41174540

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

[18F]FDG-PET reveals early postoperative cortical dysfunction after subthalamic nucleus deep brain stimulation in Parkinson's disease.

Volz C, Coenen VA, Frings L, Rijntjes M, Urbach H, Meyer PT, Sajonz BEA, Brumberg J.

Eur J Nucl Med Mol Imaging · 2025-10-02

DOI: 10.1007/s00259-025-07552-0PMID: 41037106

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Imaging Proinflammatory Microglia in Parkinson Disease Using [11C]SMW139 PET: A Multicenter Study.

Rikken RM, van de Giessen E, Brumberg J, Aarnio R, Joling M, Forsberg Morén A, Kerstens V, Moein MM, Nag S, Halldin C, Fazio P, Roos DS, Berendse HW, Kassiou M, Wahlroos S, Haaparanta-Solin M, Oikonen V, Schuit RC, Boellaard R, Windhorst AD, Jacobs AH, Lammertsma AA, Rinne JO, Varrone A, Golla SSV.

J Nucl Med · 2025-10-01

DOI: 10.2967/jnumed.125.269671PMID: 40774697

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Multimodal approach for early diagnosis of Parkinson's disease using PET imaging, tremor detection, and machine learning.

Chowdhury N, Das UK, Sazzad S, Chowdhury A, Das P.

Psychiatry Res Neuroimaging · 2025-09-12

DOI: 10.1016/j.pscychresns.2025.112063PMID: 40975035

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Enhancing interpretability of AI with radiomics-based deep neural network: proof of concept in the classification of Parkinsonian syndromes with 18F-FDG PET imaging.

Li C, Jiao F, Wu S, Wang C, Wei M, Zhang S, Wang L, Huang Y, Yin Y, Tian R, Bernhardt A, Katzdobler S, Levin J, Höglinger GU, Brendel M, Rominger A, Shi K, Zuo C, Jiang J.

Eur J Nucl Med Mol Imaging · 2025-09-11

DOI: 10.1007/s00259-025-07478-7PMID: 40932612

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

[18F]MFBG PET/CT imaging of myocardial sympathetic innervation in healthy controls and patients with parkinson's disease: dosimetry and pharmacokinetics.

Versweyveld L, Delva A, Cohilis M, Deroose CM, Van Weehaeghe D, Koole M, Vandenberghe W, Van Laere K.

Eur J Nucl Med Mol Imaging · 2025-09-09

DOI: 10.1007/s00259-025-07517-3PMID: 40924149

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

161 makale bulundu

Imaging brain class I histone deacetylase changes in the Lewy body dementias and Parkinson's disease.

Comparative evaluation of standardized imaging-guided contact selection for subthalamic deep brain stimulation in Parkinson's disease: study protocol for a randomized double-blind crossover trial.

Automated radiosynthesis and clinical experience of [<sup>18</sup>F]SMBT-1 PET imaging for <i>in vivo</i> evaluation of reactive astrocyte in Parkinson's disease: a pilot study.

CX3CR1: a potential microglia-specific PET imaging target in Alzheimer's and Parkinson's diseases.

Correlation analysis of <sup>11</sup>C-CFT PET/CT parameters with clinical characteristics of patients with early to mid-stage Parkinson's disease.

Multimodal PET/MR Imaging in Early-onset Alzheimer's Disease With Parkinsonism due to a Novel Presenilin-1 (M233I) Mutation.

Characteristics of brain glucose metabolism in Parkinson's disease patients with freezing of gait: a study based on <sup>18</sup>F-FDG PET imaging and deep learning.

[<sup>18</sup>F]FDG-PET reveals early postoperative cortical dysfunction after subthalamic nucleus deep brain stimulation in Parkinson's disease.

Imaging Proinflammatory Microglia in Parkinson Disease Using [<sup>11</sup>C]SMW139 PET: A Multicenter Study.

Multimodal approach for early diagnosis of Parkinson's disease using PET imaging, tremor detection, and machine learning.

Enhancing interpretability of AI with radiomics-based deep neural network: proof of concept in the classification of Parkinsonian syndromes with <sup>18</sup>F-FDG PET imaging.

[<sup>18</sup>F]MFBG PET/CT imaging of myocardial sympathetic innervation in healthy controls and patients with parkinson's disease: dosimetry and pharmacokinetics.

Filtreler